This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2010-09-23 Call Agenda"
Jump to navigation
Jump to search
(→Agenda) |
|||
(One intermediate revision by the same user not shown) | |||
Line 14: | Line 14: | ||
# Agenda review and approval | # Agenda review and approval | ||
#* | #* | ||
− | # Approval of minutes from previous calls: [[2010-09- | + | # Approval of minutes from previous calls: [[2010-09-16 Call Minutes|September 16th]] |
#* | #* | ||
# Review Actions from previous meeting(s) | # Review Actions from previous meeting(s) | ||
Line 28: | Line 28: | ||
#** RIM Definition is: "''Definition: a therapeutically active ingredient (player) in a mixture (scoper), where the mixture is typically a manufactured pharmaceutical. It is unknown if the quantity of such an ingredient is expressed precisely in terms of the playing ingredient substance, or, if it is specified in terms of a closely related substance (active moiety or reference substance).''". | #** RIM Definition is: "''Definition: a therapeutically active ingredient (player) in a mixture (scoper), where the mixture is typically a manufactured pharmaceutical. It is unknown if the quantity of such an ingredient is expressed precisely in terms of the playing ingredient substance, or, if it is specified in terms of a closely related substance (active moiety or reference substance).''". | ||
#* | #* | ||
− | # '''Overview | + | # '''Overview Chapter - Clinical Review & Ballot Reconciliation''' |
#* Background ballot reconciliation files (for reference only) [[Media:EHR-S Ambulatory Oncology Functional Profile, R1.zip|Ballot Results ZIP file]] and [[Media:EHR_AOFP_R1_D1_2010MAY_2010510154819 All Submitted Comments.zip|Ballot Reconciliation Worksheet(ZIP)]] | #* Background ballot reconciliation files (for reference only) [[Media:EHR-S Ambulatory Oncology Functional Profile, R1.zip|Ballot Results ZIP file]] and [[Media:EHR_AOFP_R1_D1_2010MAY_2010510154819 All Submitted Comments.zip|Ballot Reconciliation Worksheet(ZIP)]] | ||
− | #* [[Media:Ambulatory Oncology EHR Functional Profile.doc|Overview Chapter]] (Revision Markers and comments indicate proposed changes from ballot reconciliation) | + | #* [[Media:Ambulatory Oncology EHR Functional Profile.doc|Overview Chapter - All Input and Changes]] <br> (Revision Markers and comments indicate proposed changes from ballot reconciliation) |
+ | #** [[Media:Ambulatory Oncology EHR Functional Profile CDC.doc|Overview Chapter - CDC Input]] | ||
+ | #** [[Media:Ambulatory Oncology EHR Functional Profile NCI.doc|Overview Chapter - NCI Input]] | ||
+ | #** [[Media:Ambulatory Oncology EHR Functional Profile CAP.doc|Overview Chapter - CAP Input]] | ||
#* | #* | ||
# Other business | # Other business |
Latest revision as of 15:58, 23 September 2010
To return to the >> Oncology EHR Functional Profile or Agendas and Minutes
HL7 Ambulatory Oncology Functional Profile Meeting
Meeting Logistics
- Date/Time: Thursday, September 23rd, 2010 / 1:00 PM – 2:30 PM EST
- Location: Phone: 1- 770-657-9270; Passcode: 510269
- DIAL IN LOGISTICS:
- https://www.livemeeting.com/cc/cdc/join?id=K7HXG6&role=attend&pw=t%24%23T%40%7D%7D8R
- https://www.livemeeting.com/cc/cdc/join Meeting ID: K7HXG6 Participant Entry Code: t$#T@}}8R
- DIAL IN LOGISTICS:
Agenda
- Welcome and Introductions
- Agenda review and approval
- Approval of minutes from previous calls: September 16th
- Review Actions from previous meeting(s)
- Helen to contact Lori Havener (NAACCR) and Kenneth Gerlach (CDC) regarding ballot questions
- Helen to contact Lori Havener (NAACCR) and Kenneth Gerlach (CDC) regarding ballot questions
- CCHIT Liaison Report (Peter)
- CDC NPCR Project Status Update (Sandy)
- NCI Project Status Update (Salimah)
- Request to endorse the definition of "Agent" as follows:
- "An agent is a distinct substance or ingredient (as defined by FDA’s prEN ISO/CD 11238) or compound/product/mixture thereof, contained in drugs, biologics, foods, and devices that act to produce a specific effect (commonly health related). This can include radiopharmaceutical, nutritional, complimentary and alternative medicine (CAM), molecular components of devices (i.e. silicon in implants) and nano-technologic agents but does not include whole devices, or procedures (i.e. surgeries). Individual agents included in a treatment regimen or therapy (i.e. Taxotere, Adriamycin and Cytoxan) are included in this definition, however, whole regimen names or other broad classification of therapies (i.e. “CHOP”, “chemotherapy”, etc), are not."
- RIM Definition is: "Definition: a therapeutically active ingredient (player) in a mixture (scoper), where the mixture is typically a manufactured pharmaceutical. It is unknown if the quantity of such an ingredient is expressed precisely in terms of the playing ingredient substance, or, if it is specified in terms of a closely related substance (active moiety or reference substance).".
- Request to endorse the definition of "Agent" as follows:
- Overview Chapter - Clinical Review & Ballot Reconciliation
- Background ballot reconciliation files (for reference only) Ballot Results ZIP file and Ballot Reconciliation Worksheet(ZIP)
- Overview Chapter - All Input and Changes
(Revision Markers and comments indicate proposed changes from ballot reconciliation)
- Other business
- Agenda items for next meeting (tbd)